495

  1. RFK, Jr. shifts USPSTF panel’s focus away from primary care. 
  2. Pharma companies aren’t completing postmarket drug studies. 
  3. ACGME suggests eliminating some work protections for residents. 
  4. Semaglutide is good for even frail heart disease patients. 
  5. Rise of GLP-1s is making life tough for food companies.
  6. Low patient volume drags down hospital operating margins. 
  7. Elective surgeries drop as patients lose healthcare coverage.
  8. CVS Aetna streamlines prior auths for cancer. 
  9. J&J offloads closure device firm it bought just three years ago. 
  10. How will the Federal Reserve’s hike affect biotech stocks?
Get the top digital health stories right in your inbox

You might also like